Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

How Inflammation Impinges on NAFLD: A Role for Kupffer Cells
Nádia Duarte, Inês Coelho, Rita S. Patarrão, et al.
BioMed Research International (2015) Vol. 2015, pp. 1-11
Open Access | Times Cited: 114

Showing 1-25 of 114 citing articles:

Potential Role of Flavonoids in Treating Chronic Inflammatory Diseases with a Special Focus on the Anti-Inflammatory Activity of Apigenin
Rashida Ginwala, Raina Bhavsar, DeGaulle I. Chigbu, et al.
Antioxidants (2019) Vol. 8, Iss. 2, pp. 35-35
Open Access | Times Cited: 452
Innate Immunity and Inflammation in NAFLD/NASH
Marco Arrese, Daniel Cabrera, Alexis M. Kalergis, et al.
Digestive Diseases and Sciences (2016) Vol. 61, Iss. 5, pp. 1294-1303
Open Access | Times Cited: 431
Pathogenesis of nonalcoholic steatohepatitis
Wensheng Liu, Robert D. Baker, Tavleen Bhatia, et al.
Cellular and Molecular Life Sciences (2016) Vol. 73, Iss. 10, pp. 1969-1987
Open Access | Times Cited: 195
Herbal drug discovery for the treatment of nonalcoholic fatty liver disease
Tingting Yan, Nana Yan, Ping Wang, et al.
Acta Pharmaceutica Sinica B (2019) Vol. 10, Iss. 1, pp. 3-18
Open Access | Times Cited: 173
PPAR-γ signaling in nonalcoholic fatty liver disease: Pathogenesis and therapeutic targets
Hao Chen, Huabing Tan, Juan Wan, et al.
Pharmacology & Therapeutics (2023) Vol. 245, pp. 108391-108391
Closed Access | Times Cited: 103
Kupffer Cell Metabolism and Function.
Anh Thu Nguyen-Lefebvre, Anatolij Horuzsko
PubMed (2015) Vol. 1, Iss. 1
Closed Access | Times Cited: 150
Extracellular Vesicles from Amnion-Derived Mesenchymal Stem Cells Ameliorate Hepatic Inflammation and Fibrosis in Rats
Masatsugu Ohara, Shunsuke Ohnishi, Hidetaka Hosono, et al.
Stem Cells International (2018) Vol. 2018, pp. 1-15
Open Access | Times Cited: 125
Annexin A5 regulates hepatic macrophage polarization via directly targeting PKM2 and ameliorates NASH
Fang Xu, Mengmeng Guo, Wei Huang, et al.
Redox Biology (2020) Vol. 36, pp. 101634-101634
Open Access | Times Cited: 117
Anti-steatotic and anti-inflammatory roles of syringic acid in high-fat diet-induced obese mice
Ju Ri Ham, Hae-In Lee, Ra‐Yeong Choi, et al.
Food & Function (2016) Vol. 7, Iss. 2, pp. 689-697
Closed Access | Times Cited: 108
Paraoxonase-1 as a Regulator of Glucose and Lipid Homeostasis: Impact on the Onset and Progression of Metabolic Disorders
Maria João Meneses, Regina Diogo Silvestre, Inês Sousa‐Lima, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 16, pp. 4049-4049
Open Access | Times Cited: 86
The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms
Chyntia Olivia Maurine Jasirwan, Cosmas Rinaldi Adithya Lesmana, Irsan Hasan, et al.
Bioscience of Microbiota Food and Health (2019) Vol. 38, Iss. 3, pp. 81-88
Open Access | Times Cited: 81
DSS-induced colitis is associated with adipose tissue dysfunction and disrupted hepatic lipid metabolism leading to hepatosteatosis and dyslipidemia in mice
Jeonghyeon Kwon, Chungho Lee, Sungbaek Heo, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 78
Pathogenicity and virulence of Hepatitis B virus
Yu-Chen Chuang, Kuen-Nan Tsai, Jing‐hsiung James Ou
Virulence (2022) Vol. 13, Iss. 1, pp. 258-296
Open Access | Times Cited: 47
Oxidative Stress and Redox Signaling in the Pathophysiology of Liver Diseases
Raja Gopal Reddy Mooli, Dhanunjay Mukhi, Sadeesh K. Ramakrishnan
Comprehensive physiology (2022), pp. 3167-3192
Open Access | Times Cited: 44
Immunomodulation in non-alcoholic fatty liver disease: exploring mechanisms and applications
Ziwei Guo, Qinjuan Wu, Pengfei Xie, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism
Yong Zhou, Yinlu Ding, Jianliang Zhang, et al.
Biomedicine & Pharmacotherapy (2017) Vol. 97, pp. 1397-1408
Closed Access | Times Cited: 82
Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver Homeostasis
Yinhua Ni, Fen Zhuge, Mayumi Nagashimada, et al.
Nutrients (2016) Vol. 8, Iss. 7, pp. 391-391
Open Access | Times Cited: 78
Exercise and diabetes: relevance and causes for response variability
Anja Böhm, Cora Weigert, Harald Staiger, et al.
Endocrine (2015) Vol. 51, Iss. 3, pp. 390-401
Open Access | Times Cited: 73
Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice
Xianhong Du, Zhuanchang Wu, Yong Xu, et al.
Cellular and Molecular Immunology (2018) Vol. 16, Iss. 11, pp. 878-886
Open Access | Times Cited: 72
Non-alcoholic fatty liver disease (NAFLD) models in drug discovery
Banumathi K. Cole, Ryan E. Feaver, Brian R. Wamhoff, et al.
Expert Opinion on Drug Discovery (2017) Vol. 13, Iss. 2, pp. 193-205
Closed Access | Times Cited: 68
The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Ji-Young Cha, Da-Hyun Kim, Kyung–Hee Chun
Laboratory Animal Research (2018) Vol. 34, Iss. 4, pp. 133-133
Open Access | Times Cited: 65
High fructose diet-induced metabolic syndrome: Pathophysiological mechanism and treatment by traditional Chinese medicine
Ying Pan, Ling‐Dong Kong
Pharmacological Research (2018) Vol. 130, pp. 438-450
Closed Access | Times Cited: 62
Gut-Pancreas-Liver Axis as a Target for Treatment of NAFLD/NASH
Gianluca Svegliati‐Baroni, Bárbara G. Patrício, Gessica Lioci, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5820-5820
Open Access | Times Cited: 53
Key Players of Hepatic Fibrosis
Reham M. Dawood, Mai Abd El-Meguid, Ghada M. Salum, et al.
Journal of Interferon & Cytokine Research (2020) Vol. 40, Iss. 10, pp. 472-489
Closed Access | Times Cited: 50
Trem-2 Promotes Emergence of Restorative Macrophages and Endothelial Cells During Recovery From Hepatic Tissue Damage
Inês Coelho, Nádia Duarte, André Barros, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 49
Page 1 - Next Page

Scroll to top